• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I ESTRADIOL REAGENT KIT; RADIOIMMUNOASSAY, ESTRADIOL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I ESTRADIOL REAGENT KIT; RADIOIMMUNOASSAY, ESTRADIOL Back to Search Results
Catalog Number 07P50-30
Medical Device Problem Code Low Test Results (2458)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/11/2023
Type of Reportable Event Malfunction
Event or Problem Description
The customer reported a falsely depressed alinity i estradiol result for a patient on the alinity i processing module.The sample was repeated after the physician questioned the result.The following data was provided for sid (b)(6).Initial result =414.5 pg/ml (1522 pmol/l) and the repeat result = 4087.8 pg/ml (15008 pmol/l).The customer uses a reportable range: follicular: 77-921.Mid-cycle:140-2380.Luteal:77-1145.There was no reported impact to patient management.
 
Additional Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.
 
Event or Problem Description
The customer reported a falsely depressed alinity i estradiol result for a patient on the alinity i processing module.The sample was repeated after the physician questioned the result.The following data was provided for sid (b)(6).Initial result =414.5 pg/ml (1522 pmol/l) and the repeat result = 4087.8 pg/ml (15008 pmol/l).The customer uses a reportable range: follicular: 77-921 mid-cycle:140-2380 luteal:77-1145 there was no reported impact to patient management.
 
Additional Manufacturer Narrative
The complaint investigation for falsely decreased alinity i estradiol results included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, and device history record review.Trending review determined no related trend for the issue for the product.Device history record review did not identify any related non-conformances or deviations with the likely cause lot and complaint issue.The overall performance of alinity i estradiol reagents in the field was reviewed using data gathered through abbottlink from customers worldwide.The median population result for the complaint lot(s) are within established limits, indicating that the lot(s) are performing acceptably in the field.Labeling was reviewed and sufficiently addresses the customer's issue.Based on the information no systemic issue or deficiency of alinity i estradiol, lot number 50032ud00, was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I ESTRADIOL REAGENT KIT
Common Device Name
RADIOIMMUNOASSAY, ESTRADIOL
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI  N39E932
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI   N39E932
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key17789091
Report Number3005094123-2023-00254
Device Sequence Number20446663
Product Code CHP
UDI-Device Identifier00380740129927
UDI-Public00380740129927
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
EXEMPT
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 12/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/06/2023
Device Catalogue Number07P50-30
Device Lot Number50032UD00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 09/11/2023
Supplement Date Received by Manufacturer12/06/2023
Initial Report FDA Received Date09/21/2023
Supplement Report FDA Received Date12/11/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured03/16/2023
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ALNTY I PROCESSING MODU, 03R65-01, (B)(6); ALNTY I PROCESSING MODU, 03R65-01, (B)(6)
Patient SexUnknown
-
-